postanalytical phases where most errors were found to arise. 3 So, detailed information about preanalytical conditions has to be provided, as mentioned in the College of American Pathologists (CAP) checklist 4 or the International Organization for Standardization (ISO)
15189:2012 norm. 5 Among other items, the maximum delay between blood collection and analysis has to be defined. Up to now, the Clinical Laboratory and Standards Institute (CLSI) Guideline H21-A5 6 recommends that most coagulation parameters must be evaluated within 4 hours, except tests aimed at monitoring treatments with full-dose unfractionated heparin for whom the delay must not exceed 2 hours.
Similar recommendations were made by the European Concerted
Action on Thrombosis (ECAT) 7 and the Groupe Français d'Etude sur l'Hémostase et la Thrombose (GEHT).
8
The economic pressure and the rationalization of biology have led to an increasing concentration of clinical laboratories into so-called core labs, during the last years. As a consequence, the elapsed time from specimen collection to its delivery to the laboratory has dramatically increased due to longer distances between the collection and the technical sites. In such conditions, a 4-hour delay could be a limitation in some cases, making these recommendations difficult to apply in routine practice. As the careful control of preanalytical conditions, particularly the delay between blood collection and analysis, is mandatory to avoid sample deterioration that may invalidate analysis results, longer storage times were evaluated by different groups. In most cases, there were no clinically relevant changes in test results for most parameters, particularly prothrombin time (PT)/international normalized ratio (INR), for which evaluation was found to be reliably delayed for up to 3 days with changes in test results without any significant clinical relevance. 
| Aim of the study
The aim of the present study was to investigate the potential impact of prolonged storage times of unspun citrated blood collection tubes on routine coagulation test results, that is, PT/INR, activated partial thromboplastin time (aPTT), fibrinogen, coagulation factors V (FV) and VIII (FVIII), and D-dimer, and so to define optimal delays between blood collection and analysis that could be used in clinical practice. an average distance of 15 km, and storage at a temperature between +18 and +25°C. None was transferred to the laboratory by pneumatic system. Centrifugation was performed according to the recommendations of the GEHT at 2250×g and +20°C for 15 minutes, and the delay between centrifugation and analysis was below 10 minutes. 8 
| PATIENTS, MATERIALS, AND METHODS

| Design of the study
| Studied population
Samples were obtained from 144 outpatients (71 males and 73 females, with a mean age of 39 years, between 18 and 65). 39 patients were treated with vitamin K-antagonists (VKA), whereas 105 were not given any anticoagulant therapy. None was treated with any heparin derivative or any direct oral anticoagulant. No other specific inclusion and/or exclusion criteria were specified particularly regarding, for example, liver function or acute phase reaction. In addition, six tubes were drawn from healthy individuals to evaluate the potential impact of the storage time on the precision of the techniques. All patients/subjects gave their informed consent to participate in the study.
| Materials and Methods
At both participating centers, coagulation tests were performed using the same technical conditions regarding reagents and the ACL TOP 500 CTS analyzer. All were from the same manufacturer (Instrumentation Laboratory, IL, Bedford, MA, USA). Both centers participated to external quality assessment programs, and the z-scores were below 2.0 for all investigated parameters at the time of the study.
Prothrombin time (in seconds)/INR was evaluated using the HemosIL RecombiPlasTin 2G reagent, and aPTT (in seconds) using the HemosIL SynthASil reagent. Using the batch of reagent used in the study, the mean aPTT value was 32.0 seconds, with a normal range between 25.6 and 38.4 seconds, and that upper limit was defined as 1.20 fold the mean value. Fibrinogen (in g/L) was measured according to Clauss 10 using the HemosIL Fibrinogen C reagent. FV level (in international units per dL, IU/dL) was measured by a PTbased one-stage clotting assay using the HemosIL RecombiPlasTin 2G reagent and a specific FV-depleted plasma (HemosIL Factor V Deficient Plasma). FVIII level (in IU/dL) was evaluated by an aPTTbased one-stage clotting assay using the HemosIL SynthASil reagent and a specific FVIII-depleted plasma (HemosIL Factor VIII:C Deficient Plasma). D-dimer level (expressed in ng/mL fibrinogen equivalent unit: FEU) was measured using an automated latexbased immunoassay (HemosIL D-dimer HS 500); the cutoff level for exclusion of venous thromboembolism was 500 ng/mL. 
| Statistical analysis
| RESULTS
| Stability of the within-run precision with storage time
The within-run (n=6 determinations) precision, evaluated as the coefficient of variation (CV%), was determined for the studied parameters, that is, PT (in seconds), aPTT (in seconds), fibrinogen (in g/L), FV (in IU/dL), FVIII (in IU/dL), and D-dimer (in ng/mL FEU), just after blood collection (<30 minutes, T0), after a 2, a 4, a 6, an 8, a 12, and a 24-hours storage of unspun tubes between +18 and +25°C. As shown in Table 2 , the CV%
was found unchanged for all tested parameters when evaluated just after blood collection and after storage of the tubes for up to 24 hours, suggesting a lack of any significant deterioration of the samples within that time frame. Despite the small number of determinations (n=6), these values were found to be of the same order of magnitude that those provided by the reagent manufacturer that are reported in Table 1 were not found to be significant for fibrinogen, FV, and D-dimer (Table 3) .
T A B L E 1 Specification of the analytical methods used for the measurement of prothrombin time (PT)/international normalized ratio (INR), activated partial thromboplastin time (aPTT), fibrinogen, factor V and factor VIII, and D-dimer on the ACL TOP 500 CTS analyzer: reagent brand name, assay principle, and precisions established by the manufacturer (Instrumentation Laboratory) using plasma samples both in the normal (N) and in pathological (P) ranges of concentrations; the mean levels for each parameter are given between brackets. For details, see Subjects, Materials, and Methods part
Parameters Reagents Principle
Within-run precision (CV%) (n=30)
Total precision (CV%)
PT ( 
| PT/INR
Repeated-measures ANOVA demonstrated significant timedependent change for PT, and all analytical comparisons of test results obtained after a 6-and an 8-hours storage were statistically significant vs a <2-hours storage. The same was applied for INR evaluated in the 39 patients on VKA (Table 3) . However, when test results obtained after prolonged storage times were compared to baseline values, according to Bland and Altman, the mean bias was found to be below the desirable values for both PT and INR (Table 4) .
If the range from 2.00 to 3.00 was used as the usual therapeutic (Table 5) . Two patients had borderline baseline INR (1.98), which was measured above 2.00 in at least one of the samples evaluated after a 4, 6, or 8-hours storage, and one patient had a baseline INR of 3.20, which remained above 3.00 in the samples evaluated after a 4-and a 6-hours storage, but below that limit in the sample evaluated after an 8-hours storage (2.92). However, all the differences were below the imprecision of the technique (total coefficient of variation, CV=3.1%, Table 1 ) and the recommended (90th percentile CI) limits of variation for the bias. 
| aPTT
Analytical comparison of aPTT test results obtained after a 4, 6, or 8-hours storage vs a <2-hours storage demonstrated statistically significant differences. However, it could be mentioned that differences between aPTT results evaluated after storages longer than 2 hours, that is, 4, 6, and 8 hours, were not statistically significant (Table 3) .
The mean bias, calculated according to Bland and Altman, between test results obtained after a prolonged storage vs a <2-hours storage was found to be lower than 1.2%, that is, far below the desirable values for aPTT (Table 4) . While considering a prolonged aPTT as a clotting time above 38.4 seconds, which was the upper limit of the normal range using that specific lot of reagent, no case of discrepant aPTT test result could be demonstrated in the 100 untreated patients;
that is, all normal baseline aPTT test results remained within the normal range after a 4, a 6, or an 8-hours storage, and the same was applied to prolonged baseline aPTT results, which remained above the upper limit of the normal range when evaluated in samples after more prolonged storage times. The only discrepancy was demonstrated in one of the 39 patients on VKA (Table 5 ).
| Fibrinogen
Fibrinogen test results obtained after a 4-and a 6-hours storage were significantly different from those obtained after a <2-hours storage, whereas all other comparisons failed to demonstrate any significant difference ( 
| Factor VIII
Analytical comparison, performed using the Wilcoxon signed rank test, of FVIII levels measured after a 4, a 6, or an 8-hours storage vs a <2-hours storage demonstrated significant discrepancies, and the same was applied to comparison of test results obtained after storage times longer than 2 hours (Table 3) . Comparison, performed T A B L E 2 Within-run precision (n=6 determination), evaluated as the coefficient of variation (CV%), for prothrombin time (PT, in seconds, s), activated partial thromboplastin time (aPTT, in s), fibrinogen (in g/L), factor V (FV, in IU/dL), factor VIII (FVIII, in IU/dL), and D-dimer (in ng/mL FEU). CV% was determined for the different analytes just after blood collection (<30 min, T0), after a 2-h (h), a 4, a 6, an 8, a 12, and a 24-h storage at room temperature of unspun citrated tubes according to Bland and Altman, of test results measured after prolonged storage times vs a <2-hours storage, demonstrated a timedependent increase in the mean negative bias −3.2% after a 4-hours, −5.5% after a 6-hours, and −8.5% after an 8-hours storage (Figure 2 ).
The mean bias was within the desirable values of 4.9% recommended by Ricos et al. 14, 15 in the tubes stored for 4 hours (−3.2%), whereas it was slightly above that value after a 6-hours storage (−5.2%) and more importantly after an 8-hours storage (−8.5%). However, the latter values remained within the recommended limits of variation (90th percentile) of 15.5% recommended by the GEHT, 16 as shown in Table 4 . It could be mentioned that the reported increase in the absolute value of the mean bias is also concentration dependent and only noticeable for high FVIII levels. Actually, when analyzing those 11 samples with FVIII levels below 100 IU/dL, the mean bias , between test results obtained after a 4, 6, or 8-h storage vs a <2-h storage of whole blood samples at t room temperature. Comparison with current analytical quality specifications for desirable bias derived from biologic variation as defined by Ricos et al. 14, 15 , and recommended limits of variation (90% confidence interval, CI) recommended by the GEHT
16
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14,15
Recommended limits of variation (90% CI) 16 between test results obtained after a 4, a 6, and an 8-hours storage and those obtained after a <2-hours storage was found very low, that is, +1.4%, −2.4%, and −2.7%, respectively (Table 6 ). All these values were below the desirable bias of 4.9% that was established in normal individuals.
PT
In seconds
14,15
| D-dimer
D-dimer levels obtained after a 4, a 6, or an 8-hours storage were not statistically different from those evaluated after a <2-hours storage (Table 3) . When data were analyzed according to Bland-Altman, the mean bias between test results measured after a prolonged storage vs a <2-hours storage was not clinically relevant and below the desirable bias of 8.82% (Table 4) . As most of D-dimer test results were below the usually used cutoff level for VTE exclusion of 500 ng/mL, some of them being even around the lower limit of detection of the technique, we further analyzed the data set after segregating data into two groups below (n=89) and above (n=44) that threshold. As shown in Table 6 , the mean bias between d-dimer levels measured after prolonged storage times was not significantly different from those measured after a 2-hours storage, with mean bias of the same order of magnitude in the two groups. Moreover, while considering 500 ng/mL as the cutoff level to exclude the diagnosis of venous thromboembolism, only four patients would have been misclassified if D-dimer was evaluated in collection tubes stored for a prolonged time vs a <2-hours storage. All these changes were within the precision of the technique around the cutoff value of 500 ng/mL (CV=9.5%) as shown in Table 5 . 44 Most of these studies investigated patients on VKA, even though some evaluated that parameter in healthy individuals 19, 23, 25, 27, 29, 33, 37, 38, 40, 42, 43 or in patients with hepatitis. 32 It could be mentioned that such a stability of PT over time was also reported in samples collected from ill dogs that were evaluated after a delay of 24 45 or 48 hours. Activated partial thromboplastin time, which we found to be stable for 8 hours, was less studied, and the conclusions were surprisingly more heterogeneous with a maximum stability of 2, 42 40 Such a discrepancy could be related to difference in the studied populations, and/or reagents. However, the maximum storage time at room temperature could be as low as 2 hours 19 in patients treated with full dose of unfractionated heparin that were not included in the present study.
| DISCUSSION
Fibrinogen test results were found to be unaffected by a storage up to 8 hours, with mean bias below the desirable bias, 14 in line with a previous study. 18 Moreover, other studies evaluating the stability of this parameter concluded the lack of impact of storage time on fibrinogen test results up to 24 hours 23, 25, 26, 30, 32, 33 and even 48 hours.
38
The potential impact of the storage time at room temperature on clotting factor test results was far less evaluated. We found that FV results were unchanged when evaluated after a delay of 8 hours, with a mean bias below the recommended limits of variation recently published online by the GEHT. 16 FV results were previously found to be unaffected by a storage of up to 3.5 47 or 6 hours, 43 which were the maximum evaluated times in these studies, whereas two studies concluded a stability of 24 hours when the tubes were left unspun at room temperature for up to 48 hours. 28, 38 Conflicting results were reported about FVIII, with a maximum storage time at room temperature of 2 hours, 23 below 3 hours, 48 3.5 hours, 47 and between 4 and 6 hours, 38 when whole blood was kept unspun for up to 24, 6, 3.5, and 48 hours, respectively.
However, a longer stability of 24 hours was reported for FVIII in canine blood samples. 49 We found that the mean bias between test results obtained after a 4-hours storage was below the desirable bias of 4.9% recommended by Ricos et al., 14, 15 whereas it was slightly above that limit after a 6-hours storage time (−5.5%) and more significantly after an 8-hours storage of the tubes (−8.5%).
However, these values were in both cases below the GEHT recommended limit of variation. 16 The discrepancy between these two criteria is related to the evaluated population. Actually, the desirable T A B L E 6 Potential impact of the different storage time of whole blood samples at room temperature on factor VIII and D-dimer test results in patients classified according to FVIII levels below and above 100 IU/dL or D-dimer levels below and above 500 ng/mL There are potential limitations to this study. Actually, the rationale behind the present study was to know until when a sample drawn in the morning could be reliably evaluated during a classic working day. For that purpose, and for logistical reasons, we decided to evaluate storage times up to 8 hours, and not to 24 hours, as it was the case in some of the previous publications. In addition, except for PT/ INR in patients on VKA, baseline test results were within the normal range for most of the studied parameters in our patients' population.
Particularly, FVIII levels were found above 100 IU/mL in most of the studied patients, only 11 of them having levels below that level. As the lowest FVIII level was 61.9 IU/mL, our conclusion must be extrapolated with caution to patients with FVIII levels below that value.
However, as the trend was found to be toward decreasing FVIII test results with increasing storage time, the misdiagnosis as normal of a patient with mild hemophilia A or moderate von Willebrand disease is highly unlikely.
In conclusion, our study confirms that a prolonged storage time up to 8 hours could induce statistically significant changes for some routine coagulation test results, but that these changes remained within the desirable limits of variation, and had no clinical relevance. Accordingly, the measurement of PT/INR, aPTT, fibrinogen, FV, and D-dimer, using the investigated reagents/analyzer, could be reliably evaluated in citrated blood samples stored unspun between +18 and +25°C for up to 8 hours after blood collection. That optimal delay should be 6 hours for FVIII. However, the conclusions might be different if a laboratory encounters different conditions and/or analytical systems.
